August Newsmakers

August 14, 2018
By: Julie Poucher Harbin, Writer, DCI

A Conversation with Mike Krzyzewski: Duke men’s basketball head coach (St. Helena Star/Napa Valley Register)
Features Mike Krzyzewski on anti-cancer efforts/V Foundation 

Duke researchers discover how leukemia spreads to the brain (Raleigh News & Observer)
Features Dorothy Sipkins, MD, PhD

WATCH: Navigating Treatment Options for Patients With Relapsed/Refractory CLL (Targeted Oncology)
Features Danielle Brander, MD

WATCH: Dr. Brander Discusses the Frontline Treatment of CLL (OncLive)
Features Danielle Brander, MD

WATCH: Dr. Secord on Using Biomarkers to Guide Treatment Decisions in Ovarian Cancer (OncLive)
Features Angeles Secord, MD

Duke Researchers Awarded $1 Million For Prostate Cancer Research (UroToday)
Features Steven Patierno, PhD; Jennifer Freedman, PhD; Jiaoti Huang, MD, PhD; Amanda Hargrove, PhD; Terry Hyslop, PhD; Michael Kelley, MD; Megan McNamara MD; James Abbruzzese, MD; Hailiang Hu, PhD; Muthana Al Abo, MD, PhD.

Skin cancer occurrence after solid organ transplant (Dermatology Times)
Features Charles J. Puza, BA; Adela R. Cardones, MD; Paul J. Mosca, MD, PhD, MBA

WATCH: Prostate Cancer Osteomimicry in Circulating Tumor Cells in Men with Metastatic Castration Resistant Prostate Cancer (mCRPC) (UroToday at ASCO)
Features Andrew Armstrong, MD

Where Have All the T Cells Gone? (Cancer Therapy Advisor)
Features Peter Fecci, MD, PhD

NIH grows program with coordinating center at Duke University by more than $30M (Triangle Business Journal)

WATCH: What Patient Subset Will Novel Lung Cancer Treatments Work Best For? (Patient Power)
Features Jeffrey Crawford, MD

Financial Toxicity: Still Not Discussed With Cancer Patients (Medscape)
Features S. Yousuf Zafar, MD, and Amy Abernethy, MD 

An Overview of S-TRAC Trial Analyses in Patients With High-Risk RCC (Targeted Oncology)
Features Daniel George, MD

Expert Emphasizes Inclusivity in Prostate Cancer Trials (OncLive)
Features Daniel George, MD

WATCH: Sunitinib 4/2 vs 2/1 Schedule for Patients with mRCC (OncLive)
Features Daniel George, MD

WATCH: Systemic Therapy Approaches for Soft Tissue Sarcoma (OncLive
Features Richard Riedel, MD

Survival Disparity Analysis Yields Unexpected Findings in mCRPC (OncLive)
Features Susan Halabi, PhD

WATCH: Overall Survival Analysis Between African-American and Caucasian Men with mCRPC (OncLive)
Features Susan Halabi, PhD

New study finds link between teenage drinking and high-grade prostate cancer later in life (UNC Chapel Hill
Features Lauren Howard, MS

Payment Reform in Cancer Needs to Engage and Reward Patients, Experts Assert (AJMC)
Features Yousuf Zafar, MD

Duke Emerges as Key Player in National Initiative to Develop Physician-Scientists (Duke University School of Medicine
Features Gerard Blobe, MD, PhD; Chris Kontos, MD; and David Harpole, MD 

Women Deans at Duke Make History (Duke University School of Medicine)
Mary E. Klotman, MD

Dr. Thomas Polascik Receives Grant to Research Advanced MRI Prostate Screenings (Duke Surgery)
Features Thomas Polascik, MD

5 Things You Need to Know: JULY (Duke OLV)
Features Kimberly Blackwell, MD, and Michael Zalutsky, PHD, MA

PAPERS: 

Engaging Patients in Value-Based Cancer Care: A Missed Opportunity. JAMA Oncology, August 2, 2018, published online. S. Yousuf Zafar, MD; Blase N. Polite, MD, MPP; Mark McClellan, MD.

Timing and number of cutaneous squamous cell carcinomas in transplant recipients. JAMA Dermatology, 2018;154(6):727-728. Charles J. Puza, BA; Adela R. Cardones, MD; Paul J. Mosca, MD, PhD, MBA

Changes in Monocyte Populations Following Acute Aerobic Exercise in Breast Cancer SurvivorsIranian Journal of Breast Diseases. June 26, 2018. Nasim Khosravi, Erik Hanson, Vahid Farajivafa, Hamid Agha-Alinejad, Shahpar Haghighat, Mahdieh Molanouri Shamsi, Wiliam Evans, Jordan Lee, Eli Danson, Chad Wagoner, Elizabeth Harell, Kristen Nyrop, Hy Muss , David Bartlett, Cludio Battaglini.